Delivery Order SPE2DB24D2013-SPE2DB24FCGXQ
Award Date
5/29/24
Potential Completion Date
5/30/24
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product Ozempic, a diabetes medication, with a ceiling value of $3,127.39. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price pricing type, with an ultimate completion date of November 27, 2024. The contract was not set aside for any specific business...
This federal contract award is for the pharmaceutical product Ozempic, a diabetes medication, valued at $15,301.23. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price, and the ultimate completion date is February 28, 2025. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the pharmaceutical drug Ozempic, a medication used to manage diabetes, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor AmerisourceBergen Drug Corp. The contract has a ceiling value of $3,235.05 and runs through November 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the military and veterans'...
This federal contract award is for the delivery of Ozempic, a medication used to treat diabetes, to the Defense Logistics Agency (DLA). The prime contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The contract, valued at $6,487.57, has a completion date of December 14, 2023 and is a firm fixed-price delivery order. This award is part of a larger...
This federal contract award is for the procurement of Ozempic, a medication used to treat diabetes, with a ceiling value of $10,074.09. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 18, 2024. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of October 21, 2024. The contract does not have a set-aside designation, indicating open competition. This...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic, a medication used to treat diabetes, valued at $11,439.54. It is a firm fixed price contract with a completion date of December 19, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $27,886.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic, a medication used to treat type 2 diabetes, with an ultimate completion date of December 24, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a $7,105.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Ozempic, a medication used to treat type 2 diabetes, with a period of performance through June 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, valued at $9,724.60, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Ozempic, a medication used to treat type 2 diabetes, with a completion date of February 6, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award is for the delivery of Ozempic, a medication used to treat type 2 diabetes, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, valued at $10,055.07, and has an ultimate completion date of March 19, 2024. The contract is not designated with a set-aside requirement, indicating open competition....